Fertility Test Market is Significantly Growing at a CAGR of 7.2%

The global fertility test market is expected to reach USD 583.1 million by 2023 from USD 386.7 million in 2017, at a CAGR of 7.2% during the forecast period.

(EMAILWIRE.COM, April 25, 2019 ) Fertility Test Market by Product (Ovulation Predictor Kits, Fertility Monitors (Urine & Saliva-based)), Mode of Purchase (OTC, Prescription), Application (Female, Male), End User (Home care, Fertility clinics, Hospital) - Global Forecast to 2023

Growth in the market can be attributed to factors, such as increasing first-time pregnancy age, launch of advanced, easy-to-use fertility monitors with high accuracy, and increasing awareness about fertility testing.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139945432

This report broadly segments the market into products, mode of purchase, application, end user, and region.

The report covers the fertility test market across four key geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to dominate the global market in 2018.

The decline in fertility rate, rising first-time pregnancy age, and high
prevalence of PCOS (polycystic ovary syndrome) among North American women are few of the major factors contributing the large share of this regional segment. Additionally, factors such as the growing use of fertility monitoring devices for contraception, rising awareness about the benefits of ovulation monitors through social media, marketing campaigns, and e-commerce sites are increasing the adoption of fertility test in this region.

The Asia Pacific region is expected to grow at the fastest CAGR as growing number of women suffering from lifestyle disorders, rising funding/investments for the development of fertility and ovulation monitors; and manufacturers and suppliers of fertility testing products are shifting their focus towards the Asian market.

Request for Sample @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=139945432

However, the unproven accuracy of urine-based ovulation monitors in PCOS/PCOD patients and lesser precision of ovulation predictor kits to confirm ovulation are the major factors restricting market growth.

As of 2017, some of the major players operating in this market include SPD Swiss Precision Diagnostics (Switzerland), Church & Dwight (US), and Prestige Brands Holdings (US).